Skip header and navigation

4 records – page 1 of 1.

COVID-19 vaccination and cancer FAQ

https://libcat.nshealth.ca/en/permalink/chpams37451
Nova Scotia Health Authority. Cancer Care Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
4000
Available Online
View Pamphlet
As a person living with cancer, or a blood or bone marrow condition, you may have questions about COVID-19 vaccination. This pamphlet explains if the vaccine is safe for people with cancer, how well the vaccine works in people with cancer, when you should get the vaccine, and which vaccine you should get. Possible side effects are listed. Information on who to talk to if you still have questions about the vaccine, and what will happen after you get the vaccine is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Alternate Title
Coronavirus vaccination and cancer FAQ
COVID-19 vaccination and cancer frequently asked questions
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms - complications
Subjects (LCSH)
COVID-19 (Disease)--Vaccination
Cancer--Complications
Abstract
As a person living with cancer, or a blood or bone marrow condition, you may have questions about COVID-19 vaccination. This pamphlet explains if the vaccine is safe for people with cancer, how well the vaccine works in people with cancer, when you should get the vaccine, and which vaccine you should get. Possible side effects are listed. Information on who to talk to if you still have questions about the vaccine, and what will happen after you get the vaccine is provided.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4000
Less detail

COVID-19 vaccine and cancer : third doses

https://libcat.nshealth.ca/en/permalink/chpams37496
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4009
Available Online
View Pamphlet
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms
Subjects (LCSH)
COVID-19 (Disease)
Vaccines
Cancer
Specialty
Cancer Care
Abstract
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Patient Education Committee
Pamphlet Number
4009
Less detail

The 'flu shot' : information for cancer patients, survivors and family members

https://libcat.nshealth.ca/en/permalink/chpams37359
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2023.
Pamphlet Number
0031
Available Online
View Pamphlet
Patients currently on treatment for cancer should have the flu shot with an inactive (not live) vaccine. They should not have live vaccines, like the nasal spray flu vaccine. This pamphlet explains whether the flu shot will protect you from getting the flu, when flu season is, when you should have the flu shot, and what else you can do to protect yourself. It also gives a list of flu symptoms and explains what to do if you have symptoms. Websites for more information are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Influenza Vaccines
Neoplasms - therapy
Subjects (LCSH)
Cancer--Patients
Influenza vaccines
Specialty
Cancer Care
Abstract
Patients currently on treatment for cancer should have the flu shot with an inactive (not live) vaccine. They should not have live vaccines, like the nasal spray flu vaccine. This pamphlet explains whether the flu shot will protect you from getting the flu, when flu season is, when you should have the flu shot, and what else you can do to protect yourself. It also gives a list of flu symptoms and explains what to do if you have symptoms. Websites for more information are listed.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
0031
Less detail

Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax┬« 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax┬« 23 is, what…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1890
Less detail